Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
BioInfusion and other store brands provided a lot of life to Walgreens’ Q4 earnings, it was announced this week by the retailer.
Private label sales shot up by 15% compared to last year, the company said. The figure includes both products sold and marketed under the Walgreens label and “captive” brands like bioInfusion, which carry no evidence of the retailer’s affiliation.
While the company did not break out private label sales in dollars, Walgreens was on track with analysts’ predictions of 45 cents per earnings share.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in